Dana–Farber Cancer Institute

[8] All faculty and postdoctoral research fellows at Dana–Farber hold the equivalent academic positions concurrently at Harvard University.

[citation needed] Expertscape ranks its programs in aplastic anemia[9] and multiple myeloma[10] as best in the world.

[citation needed] It has been also ranked overall the fifth best cancer hospital in the United States by U.S. News & World Report.

[15] In 1969, the Foundation expanded their programs to include patients of all ages, and in 1974 was renamed the Sydney Farber Cancer Center.

[15] The Yawkey Center for Cancer Care was opened adjacent to the Smith Laboratories in 2011 to provide additional outpatient facilities.

This includes a departure from their current home and longtime affiliation with Brigham and Women's Hospital, which had been recognized among U.S. News & World Report's top cancer care facilities for 23 consecutive years.

A review of the allegations was complicated by the authors' inability to provide the original data from older papers, citing lab storage limitations.

However, she noted that a large volume of data issues in a scholar's work can be "very suggestive of an intention to mislead.

The Institute noted that, “The presence of image discrepancies in a paper is not evidence of an author's intent to deceive.

Dana-Farber's Office of Research Integrity immediately began a review of the papers and when needed, submitted corrections and retractions to the medical journals.

In total, 7 papers were retracted[5] and 31 others were corrected,[21] and, in October 2024, Laurie Glimcher stepped down as President and CEO.